Incyte Corp at Morgan Stanley Global Healthcare Conference Transcript - Thomson StreetEvents

Incyte Corp at Morgan Stanley Global Healthcare Conference Transcript

Incyte Corp at Morgan Stanley Global Healthcare Conference Transcript - Thomson StreetEvents
Incyte Corp at Morgan Stanley Global Healthcare Conference Transcript
Published Sep 12, 2022
11 pages (6328 words) — Published Sep 12, 2022
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of INCY.OQ presentation 12-Sep-22 4:30pm GMT

  
Brief Excerpt:

...Of course, of course. Herve, Christiana just to start off with, could you provide some opening remarks on the current state of the business and just recap for us what do you think some of the key milestones are that Incyte's work through in 2022? Herve Hoppenot ...

  
Report Type:

Transcript

Source:
Company:
Incyte Corp
Ticker
INCY.OQ
Time
4:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Incyte Corp Analyst and Investor Event Transcript – 2022-12-12 – US$ 54.00 – Edited Transcript of INCY.OQ corporate analyst meeting</ 12-Dec-22 2:00am GMT

Incyte Corp at Bank of America Biotech SMID Cap Conference Transcript – 2022-12-07 – US$ 54.00 – Edited Transcript of INCY.OQ presentation 7-Dec-22 1:35pm GMT

Incyte Corp at Evercore ISI HealthCONx Conference (Virtual) Transcript – 2022-11-29 – US$ 54.00 – Edited Transcript of INCY.OQ presentation 29-Nov-22 5:35pm GMT

Incyte Corp Q3 2022 Earnings Call Summary – 2022-11-01 – US$ 54.00 – Edited Brief of INCY.OQ earnings conference call or presentation 1-Nov-22 12:00pm GMT

Incyte Corp Q3 2022 Earnings Call Transcript – 2022-11-01 – US$ 54.00 – Edited Transcript of INCY.OQ earnings conference call or presentation 1-Nov-22 12:00pm GMT

Incyte Corp Q2 2022 Earnings Call Summary – 2022-08-02 – US$ 54.00 – Edited Brief of INCY.OQ earnings conference call or presentation 2-Aug-22 12:00pm GMT

Incyte Corp Q2 2022 Earnings Call Transcript – 2022-08-02 – US$ 54.00 – Edited Transcript of INCY.OQ earnings conference call or presentation 2-Aug-22 12:00pm GMT

Incyte Corp to Discuss Opzelura In Vitiligo FDA Approval Call Summary – 2022-07-19 – US$ 54.00 – Edited Brief of INCY.OQ conference call or presentation 19-Jul-22 12:00pm GMT

Incyte Corp to Discuss Opzelura In Vitiligo FDA Approval Call Transcript – 2022-07-19 – US$ 54.00 – Edited Transcript of INCY.OQ conference call or presentation 19-Jul-22 12:00pm GMT

Incyte Corp at Goldman Sachs Global Healthcare Conference Transcript – 2022-06-14 – US$ 54.00 – Edited Transcript of INCY.OQ presentation 14-Jun-22 3:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Incyte Corp at Morgan Stanley Global Healthcare Conference Transcript" Sep 12, 2022. Alacra Store. May 15, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Incyte-Corp-at-Morgan-Stanley-Global-Healthcare-Conference-T15333218>
  
APA:
Thomson StreetEvents. (2022). Incyte Corp at Morgan Stanley Global Healthcare Conference Transcript Sep 12, 2022. New York, NY: Alacra Store. Retrieved May 15, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Incyte-Corp-at-Morgan-Stanley-Global-Healthcare-Conference-T15333218>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.